Tenaya Therapeutics (TNYA) EBT (2020 - 2026)
Tenaya Therapeutics (TNYA) posted quarterly EBT of -$19.3 million for Q1 2026, up 28.26% year-over-year from -$15.0 million in Q1 2025, and up 4.48% quarter-over-quarter from -$20.2 million in Q4 2025.
Tenaya Therapeutics (TNYA) EBT (2020 - 2026) Analysis & Trends
Tenaya Therapeutics' EBT history runs 7 years deep, the most recent figure standing at -$19.3 million for Q1 2026.
- In Q1 2026, EBT rose 28.26% year-over-year to -$19.3 million; the TTM figure through Mar 2026 stood at -$83.0 million (up 21.52% YoY), while the FY2025 annual figure was -$90.6 million, up 18.48% from the prior year.
- EBT for Q1 2026 stood at -$19.3 million, up from -$20.2 million in the prior quarter.
- The five-year high for EBT was -$19.3 million in Q1 2026, with the low at -$33.5 million in Q4 2022.
- The 5-year median for EBT is -$29.1 million (2023), against an average of -$27.6 million.
- The sharpest annual moves came in 2022 and 2026: EBT slumped 137.1% in 2022, then rose 28.26% in 2026.
- Tenaya Therapeutics' EBT stood at -$33.5 million in 2022, then rose by 10.68% to -$29.9 million in 2023, then climbed by 20.37% to -$23.8 million in 2024, then advanced by 15.36% to -$20.2 million in 2025, then climbed by 4.48% to -$19.3 million in 2026.
- Business Quant data shows TNYA's EBT at -$19.3 million in Q1 2026, -$20.2 million in Q4 2025, and -$20.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 81.49 Mn |
| 10 | Tenaya Therapeutics | 151.52 Mn | 151.52 Mn | - | -43.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.39 Mn |
| Mar 31, 2026 | -19.27 Mn |
| Dec 31, 2025 | -20.18 Mn |
| Sep 30, 2025 | -20.28 Mn |
| Jun 30, 2025 | -23.28 Mn |
| Mar 31, 2025 | -26.86 Mn |
| Dec 31, 2024 | -23.84 Mn |
| Sep 30, 2024 | -25.63 Mn |
| Jun 30, 2024 | -29.43 Mn |
| Mar 31, 2024 | -32.23 Mn |
| Dec 31, 2023 | -29.94 Mn |
| Sep 30, 2023 | -29.14 Mn |
| Jun 30, 2023 | -33.27 Mn |
| Mar 31, 2023 | -31.74 Mn |
| Dec 31, 2022 | -33.52 Mn |
| Sep 30, 2022 | -30.70 Mn |
| Jun 30, 2022 | -28.40 Mn |
| Mar 31, 2022 | -31.06 Mn |
| Dec 31, 2021 | -26.15 Mn |
| Sep 30, 2021 | -18.26 Mn |